These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 7663977)

  • 21. Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.
    Soderquist RG; Mahoney MJ
    Expert Opin Drug Deliv; 2010 Mar; 7(3):285-93. PubMed ID: 20201735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delivery of nerve growth factor to brain via intranasal administration and enhancement of brain uptake.
    Vaka SR; Sammeta SM; Day LB; Murthy SN
    J Pharm Sci; 2009 Oct; 98(10):3640-6. PubMed ID: 19156912
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Getting into the brain: approaches to enhance brain drug delivery.
    Patel MM; Goyal BR; Bhadada SV; Bhatt JS; Amin AF
    CNS Drugs; 2009; 23(1):35-58. PubMed ID: 19062774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diffusion in brain extracellular space.
    Syková E; Nicholson C
    Physiol Rev; 2008 Oct; 88(4):1277-340. PubMed ID: 18923183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progress and problems in the application of focused ultrasound for blood-brain barrier disruption.
    Vykhodtseva N; McDannold N; Hynynen K
    Ultrasonics; 2008 Aug; 48(4):279-96. PubMed ID: 18511095
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug targeting to the brain.
    Pardridge WM
    Pharm Res; 2007 Sep; 24(9):1733-44. PubMed ID: 17554607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Approaches to neural tissue engineering using scaffolds for drug delivery.
    Willerth SM; Sakiyama-Elbert SE
    Adv Drug Deliv Rev; 2007 May; 59(4-5):325-38. PubMed ID: 17482308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. From the liver to the brain across the blood-brain barrier.
    Teichberg VI
    Proc Natl Acad Sci U S A; 2007 May; 104(18):7315-6. PubMed ID: 17463093
    [No Abstract]   [Full Text] [Related]  

  • 29. The blood-brain barrier: bottleneck in brain drug development.
    Pardridge WM
    NeuroRx; 2005 Jan; 2(1):3-14. PubMed ID: 15717053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diffusion of nerve growth factor in rat striatum as determined by multiphoton microscopy.
    Stroh M; Zipfel WR; Williams RM; Webb WW; Saltzman WM
    Biophys J; 2003 Jul; 85(1):581-8. PubMed ID: 12829512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of the carmustine implant.
    Fleming AB; Saltzman WM
    Clin Pharmacokinet; 2002; 41(6):403-19. PubMed ID: 12074689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.
    Thorne RG; Frey WH
    Clin Pharmacokinet; 2001; 40(12):907-46. PubMed ID: 11735609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain.
    Mahoney MJ; Saltzman WM
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4536-9. PubMed ID: 10200297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems.
    Saltzman WM; Mak MW; Mahoney MJ; Duenas ET; Cleland JL
    Pharm Res; 1999 Feb; 16(2):232-40. PubMed ID: 10100308
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localized delivery of proteins in the brain: can transport be customized?
    Haller MF; Saltzman WM
    Pharm Res; 1998 Mar; 15(3):377-85. PubMed ID: 9563066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging.
    Martínez-Serrano A; Björklund A
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1858-63. PubMed ID: 9465107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of drugs following controlled delivery to the brain interstitium.
    Mak M; Fung L; Strasser JF; Saltzman WM
    J Neurooncol; 1995 Nov; 26(2):91-102. PubMed ID: 8787851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of nerve growth factor following direct delivery to brain interstitium.
    Krewson CE; Klarman ML; Saltzman WM
    Brain Res; 1995 May; 680(1-2):196-206. PubMed ID: 7663977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transport and elimination of recombinant human NGF during long-term delivery to the brain.
    Krewson CE; Saltzman WM
    Brain Res; 1996 Jul; 727(1-2):169-81. PubMed ID: 8842395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stabilization of nerve growth factor in controlled release polymers and in tissue.
    Krewson CE; Dause R; Mak M; Saltzman WM
    J Biomater Sci Polym Ed; 1996; 8(2):103-17. PubMed ID: 8957707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.